.Merck trumps incomes assumptions, raises sales outlook on strong requirement for best medications like Keytruda CNBCMerck & Co. (MRK US) Beats Profit Forecasts as Keytruda Sales Increase BloombergMerck Sell: Pharma Titan Posts Solid Outcomes, However Outlook Drops Short Capitalist's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats earnings and also sales assumptions amid Keytruda strong point, yet gives blended full-year expectation MarketWatch.